All posts by imreal

Opening of the New Aunt Leah’s House for Vulnerable Moms and Babies Marks its 35th Anniversary


“For 35 years this house has been dedicated to keeping families together. During this time more than 400 families have called Aunt Leah’s house home, and we are honoured to continue to serve our community in this way,” said Sarah Stewart, Executive Director of Aunt Leah’s Place.

Aunt Leah’s Foundation announced today the completion of its most recent social purpose housing project, the rebuilding of the original Aunt Leah’s House. Operated by Aunt Leah’s Place, since the 1980’s, Aunt Leah’s House has been a safe haven for young moms (often in foster care themselves) and their babies to ensure families remain together and not separated by the child welfare system.

Through the Thresholds Program, delivered by Aunt Leah’s Place, mothers are provided with a safe and caring home environment to live in, where they learn how to care for their baby with the guidance of staff and family support workers. “For 35 years this house has been dedicated to keeping families together,” said Sarah Stewart, Executive Director of Aunt Leah’s Place. “During this time more than 400 families have called Aunt Leah’s house home, and we are honoured to continue to serve our community in this way.”

A former foster parent herself, Gale Stewart, Founder of Aunt Leah’s, and B.C. Medal of Good Citizenship Award recipient, saw first-hand the importance of “beginnings” as it applied to the bonding of mom & baby and how she could create a home where these young moms could enjoy the comfort of a lovely space, good food and intimate times with their newborns. The new purpose-built home will have four bedrooms with attached bathrooms, a large training kitchen, office space and a second stage self-contained suite that a mom can graduate into.

“Together we will continue to provide comfortable beginnings for vulnerable moms and babies, helping to re-unite and keep families together,” said Gale Stewart.

In 2020, pandemic restrictions and protocols limited the number of moms that could be accommodated in an aging house, and repairs and maintenance costs increased to the point where the original house was no longer operable. Aunt Leah’s Foundation undertook the rebuilding of the original house. The project was funded in part by the Government of Canada’s Reaching Home program, Canada Mortgage and Housing Corporation’s National Housing Co-Investment Fund and the Government of British Columbia’s Community Gaming Grants Capital Projects program, as well as a number of generous private donors. “Despite the challenges of fundraising and executing a project during pandemic times, it was the critical support of our partners, government funders and donors who believed in its importance that made it possible,” said Jacqueline Dupuis, Executive Director, Aunt Leah’s Foundation.

“Every Canadian deserves a safe and affordable place to call home,” said The Honourable Ahmed Hussen, Minister of Housing and Diversity and Inclusion. “Our government is proud to support the redevelopment of Aunt Leah’s House, a home where mothers can rest, grow and regain their independence in a safe and secure environment. At Aunt Leah’s, mothers will have the opportunity to rebuild their lives and access the critical support services necessary for them to emerge stronger. This is one way our government’s National Housing Strategy is ensuring no one is left behind.”

“Aunt Leah’s House provides a crucial service to those most vulnerable in our society. Its rebuilding ensures that more mothers and children will receive safe housing and services they need,” said Anne Kang, Minister of Municipal Affairs. “By funding important projects like this, the Province is helping support a brighter future for mothers, families and their little ones entering the world.”

About Aunt Leah’s Place

For over 30 years, Aunt Leah’s Place has been helping kids in foster care and young mothers achieve a better future. We do this by providing guidance, supported housing, job training and coaching on essential life skills. We believe every individual deserves to feel safe, cared for, and have a sense of belonging. Unfortunately, this is not a reality for many teens in the foster care system. When they “age out” of government care at 19, they find themselves completely alone. Aunt Leah’s often provides the only thread of care and continuity for youth whose lives are marked by abuse, neglect, abandonment, and multiple foster home placements. Over the years, we have seen how support at this critical time can help these young people realize their potential while becoming resilient, independent adults.

About Aunt Leah’s Foundation

In 2013, recognizing the need for more housing options, Aunt Leah’s Place launched a foundation for the purpose of building a social purpose housing portfolio that would provide safe, affordable housing for new mothers and young people leaving foster care. Today the Foundation has a portfolio of four shared-living homes and an 11-unit apartment building, housing 25-30 at-risk youth each year. Most recently the Foundation undertook a project to rebuild the original Aunt Leah’s House.

Aunt Leah’s Story: https://trellis.org/rebuild-aunt-leahs-house

Gale Stewart – BIO

Gale was born and raised rurally in southern Ontario. She graduated in Radio Television Arts at the Ryerson Polytechnic Institute (now called Toronto Metropolitan University) and moved to B.C. with a young family in 1972.

Housing has always been a very important part of Gale’s life. Finding and providing homes is her passion. They were Foster Parents during the 80’s and they saw, first-hand, the lack of housing, support and tenancy skills offered to teenagers as they aged out of the government foster care system on their 19th birthday. Through that experience and the help of many folks, she has had the privilege of founding two charities: Aunt Leah’s Place that provides support to youth and young moms leaving foster care and a partnering charity, Aunt Leah’s Foundation that buys, builds, and maintains housing for these young people.

Along with enjoying her four adult children and seven grandchildren she is currently helping to set up a Legacy Program for Aunt Leah’s Place, and she is in the early stages of writing the “Aunt Leah’s Story.”

Among many accolades for her important work, Gale is the recipient of the 2021 B.C. Medal of Good Citizenship Award.

Jacqueline Dupuis – BIO

Jacqueline moved to Vancouver in 2012 as the Executive Director of the Vancouver International Film Festival. After 8 years leading one of Vancouver’s largest arts and cultural institutions, Jacqueline followed her heart and shifted her focus to the social impact sector where she became the Executive Director of Aunt Leah’s Foundation.

Jacqueline thrives when she is working on complex problems and she believes in the role of organizations to tell powerful stories, create connection, and affect positive change in the world. Her leadership work focuses on developing growth-oriented business models and strong organizational cultures.

A travel junkie, Jacqueline has traveled the world for both work and pleasure. She has been featured in the media as both an organizational representative and public figure and was honoured to be included in the 2015 YWCA Vancouver Women of Distinction Awards.

Record-Breaking Health Care M&A Activity Recorded in 2022, According to Acquisition Data From LevinPro HC


News Image

The decline in activity we saw at the end of 2022 can be attributed to the rising interest-rate environment that represented a challenge for investors… Fears of a recession that may occur in 2023 also led to many investors re-evaluating valuations.

Health care merger and acquisition activity skyrocketed in 2022 to an all-time high of 2,395 transactions. This represented an 8% increase over the previous record of 2,214 deals recorded in 2021.

“Deal totals throughout the various sectors of health care reflect the limited downside risks faced by investors who are deploying capital in what is a significant and growing part of the U.S. economy,” said Glenn Kalinoski, Healthcare Editor at Irving Levin Associates LLC, which publishes the data on its LevinPro HC platform. “Amid declining stock markets in 2022, investors are looking for safety and what many view as predictable returns.”

Activity in the Physician Medical Groups sector soared 33% in 2022 as 608 deals were announced, compared with only 457 transactions in 2021. Biotechnology also generated a double-digit percentage rise in activity, gaining 17% with 141 deals in 2022 from 121 transactions in 2021.

The Other Services sector generated a 20% gain with 574 deals in 2022 compared with 477 transactions in 2021. Other Services includes subsectors such as ambulatory surgery centers, fertility storage solutions, health insurance support services and medical transportation services. The Medical Office Building subsector accounted for much of the increase, with 214 transactions in 2022 compared with 160 in 2021, representing a 34% jump.

Acquisitions by private equity firms continued the trend of being a more significant element of healthcare M&A activity. The 952 private equity deals in 2022 represented a 12% increase over the 852 transactions in 2021, and a 127% jump compared with the 419 deals recorded in 2020.

Headwinds began appearing in healthcare M&A activity at the end of 2022 as 547 deals were reported during the fourth quarter. This represented a 15% drop from the 647 transactions recorded during the final quarter of 2021. The first three quarters of 2022 produced increases compared to the same periods in 2021, including: 608 deals in the third quarter, representing a 17% increase over 520 transactions; 597 transactions in the second quarter for a 22% rise compared to 488 deals; and 643 deals in the first quarter, representing a 15% increase compared with 559 transactions.

Deal value in 2022 totaled $250 billion based on 482 transactions with disclosed prices. The dollar amount represented a 48% drop from 2021 when deal value reached $476.6 billion based on 615 transactions that had disclosed prices. In 2020 deal value totaled $270.6 billion based on 486 transactions with disclosed prices. The most expensive acquisition of 2022 was announced on December 12 as biopharmaceutical company Amgen Inc. purchased Horizon Therapeutics plc for $27.8 billion.

“The decline in activity we saw at the end of 2022 can be attributed to the rising interest-rate environment that represented a challenge for investors,” Kalinoski said. “Fears of a recession that may occur in 2023 also led to many investors re-evaluating valuations.”

Irving Levin Associates is celebrating 75 years of delivering exclusive M&A intelligence to its sophisticated audience of seniors housing and healthcare investors. The company was established in 1948 and has offices in New Canaan, Connecticut, and North Bethesda, Maryland. The company publishes research reports and newsletters, and maintains databases on the healthcare and senior housing M&A markets.

Share article on social media or email:

RARE-X and CoRDS Collaborate to Improve Patient Outcomes for Rare Diseases


News Image

“By collaborating with RARE-X, we can help ensure we can support expanded data collection and interoperability between existing CoRDS registries and RARE-X,” said Dr. David Pearce, president of Sanford Research.

RARE-X, the Global Genes patient-driven data collection platform, today announced a collaboration with Coordination of Rare Diseases at Sanford (CoRDS), enabling rare disease patients to better share their data and accelerate the development of diagnoses and treatments. In addition, patient advocacy groups already working with CoRDS will have the opportunity to expand and interconnect their data by leveraging RARE-X’s shared federated data platform.

With more than 10,000 rare diseases worldwide, rare disease groups struggle to compile rich, longitudinal patient data and clinical natural history data. This information is critical for patients and their doctors to understand their diseases better, entice researchers and biopharma to invest in their diseases, and help determine meaningful clinical endpoints. This collaboration will help break down data silos to make rich natural history data accessible to rare disease groups and researchers.

“CoRDS already helps link patients to researchers and clinical trials that are available for them,” said Dr. David Pearce, president of Sanford Research. “By collaborating with RARE-X, we can help ensure we can support expanded data collection and interoperability between existing CoRDS registries and RARE-X.”

RARE-X recognizes the many data gaps that exist in rare disease research and understands the importance of data sharing and data interoperability for researchers. RARE-X offers an automated and structured platform to support standardized data collection while enabling patient communities with proper governance, consent, and technology that can support a data ecosystem built for discovery.

“We are collaborating with CoRDS to expand the gathering of patient-reported outcomes from their health data,” said Charlene Son Rigby, CEO of Global Genes. “CoRDS shares the same commitment to patients as we do, and we are honored to collaborate with them to provide patients the ability to interconnect their data, making it easily accessible for researchers, to accelerate disease understanding and therapy development.”

About RARE-X

RARE-X is a program of Global Genes focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Enabled by best-in-class technology, patients, researchers, and other technology vendors, RARE-X gathers structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data-sharing technology. Through RARE-X, Global Genes is building the largest collaborative patient-driven, open-data access project for rare diseases globally. For more information, visit http://www.rare-x.org.

About Sanford Health

Sanford Health, the largest rural health system in the United States, is dedicated to transforming the health care experience and providing access to world-class health care in America’s heartland. Headquartered in Sioux Falls, South Dakota, the organization serves more than one million patients and 220,000 health plan members across 250,000 square miles. The integrated health system has 47 medical centers, 2,800 Sanford physicians and advanced practice providers, 170 clinical investigators and research scientists, more than 200 Good Samaritan Society senior care locations and world clinics in 8 countries around the globe. Learn more about Sanford Health’s commitment to shaping the future of rural health care across the lifespan at sanfordhealth.org or Sanford Health News.

About Global Genes

Global Genes is a 501(c)(3) non-profit organization dedicated to eliminating the burdens and challenges of rare diseases for patients and families globally. In pursuit of that mission, Global Genes connects, empowers, and inspires the rare disease community to stand up, stand out, and become more effective on their own behalf ⁠— helping to spur innovation, meet essential needs, build capacity and knowledge, and drive progress within and across rare diseases. Global Genes serves more than 400 million people around the globe, and nearly one in 10 Americans affected by rare diseases. If you or someone you love has a rare disease or are searching for a diagnosis, contact Global Genes at 949-248-RARE or visit the Resource Hub.

###

Tom Hume

Marketing Communications – Global Genes/RARE-X

tom.hume@globalgenes.org

Share article on social media or email:

Slone Partners Places Paul Wotton, Ph.D. as Chair of Board of Directors at Kytopen


Kytopen

“Paul Wotton is an extremely accomplished and talented leader and visionary in biotech, advanced cell technology, and biopharmaceutical research, discovery, and marketing,” said Slone Partners CEO Leslie Loveless.

Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Paul K. Wotton, Ph.D., as Chair of the Board of Directors at Kytopen, an MIT startup biotechnology company leading advancements in novel high-throughput cellular and genome engineering platforms.

An experienced CEO, Board Member, inventor, and serial entrepreneur, Dr. Wotton was recently named a “Top 100 Innovation CEO” by World Biz Magazine and won the Ernst & Young Entrepreneur of the Year Regional (NJ) Life Sciences award in 2014.

Over the course of his remarkable career, Dr. Wotton has served as President and Chief Executive Officer (CEO) at Ocata Therapeutics and as President and CEO of Antares Pharma. He currently serves on the Board of Directors of Vericel Corporation (NASDAQ: VCEL) and Cynata Therapeutics (ASX: CYP) and is a founder of Avenge Bio.

“Paul Wotton is an extremely accomplished and talented leader and visionary in biotech, advanced cell technology, and biopharmaceutical research, discovery, and marketing,” said Slone Partners CEO Leslie Loveless. “He brings tremendous passion and depth of knowledge to his new role as Chair of the Board of Directors at Kytopen.”

“We are thrilled to welcome Paul Wotton to join and lead the Kytopen Board of Directors,” said Dr. Paulo Garcia, CEO and Co-Founder of Kytopen. “Dr. Wotton not only brings significant experience growing biotech companies but also has the vision and aspiration to help Kytopen deliver on our mission to expand patient access to the next generation of living medicines.”

Dr. Wotton commented, “I am very pleased to join Kytopen at such an exciting time in our industry. Kytopen’s proprietary non-viral delivery technology solves a major bottleneck in the process of gene-modified cell therapy discovery, development, and manufacturing; a bottleneck that keeps costs high, limits productivity, and constrains patient access to potentially life-saving medicines.”

Dr. Wotton received his Ph.D. in Pharmaceutical Sciences from the University of Nottingham.

ABOUT SLONE PARTNERS

Slone Partners delivers the leaders who build amazing and diverse life sciences and healthcare organizations – People Are Our Science®. Founded in 2000, Slone Partners specializes in delivering world-class C-suite leadership, executive, and upper management talent to the most promising and established biotech, diagnostics, research tools, healthcare, precision medicine, medical device, and laboratory services companies. With national and global clients, Slone Partners uniquely and precisely provides an array of executive search and advisory services, including diversity, equity, and inclusion strategy, to innovative life sciences and healthcare companies. To learn more about Slone Partners’ value proposition and processes, visit http://www.slonepartners.com or call 888.784.3422.

ABOUT KYTOPEN

Kytopen is an MIT startup developing platforms to accelerate the discovery, development, and manufacturing of gene-modified cell therapies. The scalable Flowfect® solution combines microfluidics and automation to make this process easier, faster, and more cost-effective than the state-of-the art solutions. In 2017, Dr. Paulo Garcia co-founded Kytopen with Dr. Cullen Buie. Together they co-invented Kytopen’s proprietary Flowfect® technology for high-throughput genetic modification of cells. For more information, visit http://www.kytopen.com and follow @kytopen on Twitter and LinkedIn. Kytopen products are provided for Research Use Only.

Share article on social media or email:

Devery McDowell’s newly released “From the Biggest Book of Bible…


“From the Biggest Book of Bible Stories: The Magnificent 7 Series” from Christian Faith Publishing author Devery McDowell is a charming opportunity for young readers to learn about key figures and…

(PRWeb January 12, 2023)

Read the full story at https://www.prweb.com/releases/devery_mcdowells_newly_released_from_the_biggest_book_of_bible_stories_the_magnificent_7_series_is_a_creative_collection_of_classic_biblical_stories/prweb19109456.htm

Wanda Edwards’s newly released “You Have Ravished My Heart” is a…


“You Have Ravished My Heart” from Christian Faith Publishing author Wanda Edwards is an engaging and thought-provoking narrative that brings the Song of Solomon to life like never before.

(PRWeb January 12, 2023)

Read the full story at https://www.prweb.com/releases/wanda_edwardss_newly_released_you_have_ravished_my_heart_is_a_creative_adaptation_of_the_song_of_solomon/prweb19106857.htm

Can We Find Our Way?” is an informative discussion of how to form a connection with God


News Image

“Seeking Christ II: Can We Find Our Way?”: an encouraging approach to learning where to start in the process of building an active spiritual experience. “Seeking Christ II: Can We Find Our Way?” is the creation of published author David A Jamadar.

Jamadar shares, “Seeking Christ II is a ‘how to’ book hopefully helping us to understand some of the practices that we can employ to move closer to our Holy Father. Mostly based on the experiences of the author, it starts with trying to understand why we should even want to get to know Christ, then it discusses what the Bible calls ‘flesh’ and the ‘old man,’ referred to in these pages as the ego. Most of the book describes methods or practices which suggest how we may move into relationship with Christ as we align ourselves with our Holy Father. Discussed are a powerful prayer of surrender, what it means to be ‘born again,’ how one may ‘see’ with the ‘eye of the heart,’ and how we may function as optimal conduits for the gifts of the Spirit. Brief descriptions of surrender, mindfulness, and divine reading and the idea of hearing from God are included. Finally, some ideas are presented that have stymied and continue to challenge the author, ending with a summary of the author’s understanding one perspective of who we truly are (the new man) and how we may optimize our efforts to be receptive to the wishes of our Holy Father as we function as a conduit for the gifts of the Spirit.

“The author was encouraged to write this book by an encounter with the Holy Spirit over a week-long period of time and has included some testimonies and other interactions scattered throughout the text. The author has tried to offer a Biblical scriptural basis for his conclusions obtained mostly through study and prayer but also through interaction with the Holy Spirit. This book is offered in prayer with the hope that something in these pages may help the reader develop a stronger, intimate, and more loving relationship with our Holy Father.”

Published by Christian Faith Publishing, David A Jamadar’s new book will encourage readers as the author offers personal experiences and testimony to back up the thoughtful message within.

Consumers can purchase “Seeking Christ II: Can We Find Our Way?” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Seeking Christ II: Can We Find Our Way?,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Embryo Adoption Pioneer Agency Reaches 1,000th Milestone Birth!


1,000th MILESTONE BIRTH

“Snowflakes provided us renewed hope in starting our family at a time when hope seemed lost. “

NCA Snowflakes® Embryo Adoption, the only accredited embryo adoption program in the world, has announced the one-thousandth birth of a child resulting from the agency’s efforts to match donated frozen embryos with adopting families.

Snowflakes babies one-thousand and one-thousand-one were born on December 23, 2022 to parents Rodney and Mary Leah Miller of Birmingham, Alabama, “We are absolutely thrilled at the arrival of our blessings, Dalton and Mary Elizabeth, and cannot thank the people at Snowflakes enough for the role they played in this miracle. Snowflakes provided us renewed hope in starting our family at a time when hope seemed lost. We are grateful that we were able to provide our adopted embryos a chance to be the people the Lord created them to be. Because of the Snowflakes program Mary Leah was able to experience the joys of pregnancy. While our journey has been long, and not as we originally envisioned, we can now look back at how the Lord has guided each of our steps and honestly say we wouldn’t change a single thing about it.”

Snowflakes® Embryo Adoption was established in 1997 to help families with remaining embryos from their IVF treatment choose a family to adopt and attempt to give birth to those adopted embryos. Many families who have had failed IVF cycles turn to embryo adoption and successfully give birth. The Snowflakes program helps families donate embryos and adopt embryos in all 50 states.

“We are an adoption agency committed to helping children in all stages of their biological development.” says Kimberly Tyson, Vice-President of Snowflakes®. “One-thousand babies born through the Snowflakes program is an affirmation of the viability of embryo adoption. It is an adoption choice that helps families with remaining embryos select an adopting family, rather than simply donating their embryos anonymously through a fertility clinic. Both donor and adopting couples are often unaware that embryo adoption is available. We are working hard to continually raise awareness on this important option for families.”

According to Nightlight Christian Adoptions (NCA) president, Daniel Nehrbass, the NCA Snowflakes® program not only helps couples build families in a unique way, but also helps other families who aren’t sure what to do with remaining embryos after successful rounds of traditional IVF, “The 1000th Snowflake baby reminds us that you can give birth to your adopted child. Nightlight Christian Adoptions offers a way to give every embryo a chance at life and reduces the number of embryos in frozen storage. If a woman has difficulty conceiving, but is able to carry a baby, Snowflakes embryo adoption is probably the right adoption program for her.”

For more information about the NCA Snowflakes® Embryo Adoption program visit:

https://nightlight.org/snowflakes-embryo-adoption-donation/anniversary-landing-page/

https://nightlight.org

Share article on social media or email:

SITC Releases Executive Summary from the Crisis in Clinical Research Virtual Summit


Webinar banner

On Aug. 17, 2022, the Society for Immunotherapy of Cancer (SITC) convened key oncology experts from academia, industry and government, including the FDA and NCI, to lead a national conversation to address a crisis in clinical research. Limited patient access to clinical trials and slowed drug development due to staffing shortages, administrative burden, and current business models have led to drastically reduced capacity to conduct potentially lifesaving oncology clinical trials.

The virtual summit convened over 600 stakeholders and 30 panelists to discuss the multi-faceted problems in oncology clinical research today. From this summit, SITC has created an Executive Summary document that outlines the existing problem, the summit goals and proposed solutions that could expand access to clinical trials for patients and increase capacity at sites conducting the trials.

“The overall goal of this summit was to better define the issues that exist and discuss possible solutions to this critical situation,” said SITC President Leisha Emens, MD, PhD. “This incredible event crystalized the core issues through robust discussions with relevant stakeholders that ultimately brought the crisis into the national spotlight.”

SITC’s proposed solutions for addressing the crisis facing clinical research include:

  • Standardization and Centralization of Clinical Research Resources
  • Cross-institutional Data Availability
  • Maximizing Efficiency Across Clinical Research Operations
  • Diversification of Clinical Research Sites and Populations

This executive summary, created as a tangible deliverable from the summit, also includes the next steps that SITC is working on with relevant stakeholders in an effort to address the four key takeaways.

“We appreciate that SITC can’t solve this national, complex crisis alone,” stated Mary Dean, JD, CAE, SITC’s Executive Director. “We are working diligently to rally key stakeholders in a strategic, action-based conversation that will ultimately provide access to critically important clinical trials.”

SITC’s Crisis in Clinical Research Virtual Summit full executive summary, presentation recordings along with panelist and organizer information is available on the SITC web site at sitcancer.org/crisis.

About SITC

Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on Twitter, LinkedIn and YouTube.

Share article on social media or email:



AxisCare Expands Senior Leadership Team In The Areas Of Customer Support, Sales, & Marketing


“These additions to the AxisCare’ senior leadership team and their cumulative expertise in the areas of team management, growth, and strategic thinking are exactly the right fit for AxisCare’s next phase of growth” -Todd Allen, CEO & Co-Owner of AxisCare.

AxisCare, an international provider of scheduling and management software for non-medical home care businesses, today announced the hiring three key leaders in late 2022: Matt Bonow as Director of Customer Support, Josh Lawson as VP of Growth, and Kendra Pulliam as VP of Marketing. The strengthening of the AxisCare leadership team will allow the company to support its rapid growth and accelerate operational excellence across its customer support, sales and marketing functions.

The expanded leadership includes:

Matt Bonow appointed as Director of Customer Support: Bonow joins AxisCare from his prior management role at the Department of Veterans Affairs. He will leverage his extensive experience in managing large teams to grow AxisCare’s customer support department to be able to match the rapid growth of the company’s user base and help customers grow in their understanding of the AxisCare platform.

Josh Lawson appointed as VP of Growth: Lawson is a results-driven leader with a track record of driving sustainable business growth through data analysis, customer-centric strategies, and team development. He has built and scaled company growth both in non-profit as well as the tech start-up world, and brings significant experience in growing sales teams in a hyper-growth environment.

Kendra Pulliam appointed as VP of Marketing: Pulliam is an accomplished marketing executive with experience in spearheading the strategic development, nurturing, and management of a brand vision. Her extensive background includes stints at Southwest Airlines, Baylor University and Essentium, a leader in the 3D printing industry. She will lead the marketing activities for AxisCare, including brand, digital marketing, demand generation, public relations, events, and internal communications.

“These additions to the AxisCare’ senior leadership team and their cumulative expertise in the areas of team management, growth, and strategic thinking are exactly the right fit for AxisCare’s next phase of growth” says Todd Allen, CEO and co-owner of Axiscare. “We are excited to welcome Kendra, Josh, and Matt to AxisCare, and look forward to the ways they will leverage their individual skill sets on behalf of our team.”

About AxisCare

AxisCare’s agency management software is a back-office and point of care solution for non-medical agencies in all 50 states and 6 countries. Specializing in Private Pay, Medicaid, VA Billing and other 3rd-party payers, AxisCare’s platform helps agencies from SMB to franchises to enterprise agencies, stay compliant, cash-flow healthy, and ahead of their competition with built-in marketing and CRM tools, user-friendly scheduling, built-in payroll, business intelligence, automatic payments, and more. Recently given the industry’s top award for ease of use, overall performance and customer service, AxisCare’s mission is to transform home operations, empowering agencies to provide better care. For more information about AxisCare, please visit axiscare.com.

Media Contact:

Taylor Stack

Communications Marketing Specialist

taylorstack@axiscare.com

axiscare.com

Share article on social media or email: